These Analysts Lower Their Forecasts On NOV Following Q3 Results
These Analysts Lower Their Forecasts On NOV Following Q3 Results
NOV said it expects fourth-quarter consolidated revenues to be down 3% – 5% year-over-year with adjusted EBITDA of $280 million to $300 million.NOV Inc. (NYSE:NOV) posted weak results for the third quarter, after the closing bell on Thursday.
華高（紐交所:NOV）週四收盤後發佈了第三季度疲弱的業績。
NOV reported quarterly sales of $2.19 billion which missed the analyst consensus estimate of $2.23 billion. The company reported quarterly earnings of 33 cents per share which missed the analyst consensus estimate of 36 cents per share.
華高報告第一季度銷售額爲21.9億美元，低於分析師一致預期的22.3億美元。公司報告每股收益爲33美分，低於分析師一致預期的36美分。
"During the third quarter of 2024, NOV continued to improve cash flow, backlog, profitability and margins compared to the prior year," stated Clay Williams, Chairman, President, and CEO. "Revenues improved modestly compared to the third quarter of 2023, with strong execution on our growing backlog, increasing demand for aftermarket parts and services, and greater business efficiency driving margins higher. Additionally, demand for our capital equipment continued to grow in support of long-cycle offshore and international projects with NOV achieving a book-to-bill of 111% during the quarter, and 123% year-to-date."
「在2024年第三季度，華高繼續改善現金流、訂單、盈利能力和利潤率，與去年同期相比有所提升，」華高董事長、總裁兼首席執行官克萊·威廉姆斯表示。 「收入與2023年第三季度相比略有提升，我們不斷執行訂單簿，服務後市場零件和服務需求持續增加，業務效率提升推動利潤率上升。此外，對我們的資本設備的需求繼續增長，支持長週期的海上和國際項目，華高在本季度實現了訂單額佔銷售額的111%，年初至今爲123%。」
NOV said it expects fourth-quarter consolidated revenues to be down 3% – 5% year-over-year with adjusted EBITDA of $280 million to $300 million.
據華高表示，預計第四季度合併收入同比下降3%-5%，調整後的EBITDA爲28000萬美元至30000萬美元。
NOV shares gained 0.4% to trade at $15.78 on Monday.
週一，華高股價上漲0.4%，報15.78美元。
These analysts made changes to their price targets on NOV following earnings announcement.
這些分析師根據業績公告對華高的目標價進行了調整。
- Stifel analyst Stephen Gengaro maintained NOV with a Buy rating and lowered the price target from $25 to $24.
- Susquehanna analyst Charles Minervino maintained the stock with a Positive and cut the price target from $22 to $21.
- 斯提弗爾分析師史蒂芬·根加羅維持買入評級，將目標價從25美元下調至24美元。
- Susquehanna分析師查爾斯·米納維諾維諾維持正面評級，並將目標價從22美元下調至21美元。
Considering buying NOV stock? Here's what analysts think:
考慮購買華高股票？這是分析師的看法：
Read More:
閱讀更多：
- Top 3 Industrials Care Stocks That Plunge This Month
- 本月股票市場中表現下跌的前三家工業保健股
譯文內容由第三人軟體翻譯。
